Merck dealt blow in Fosamax case

Jury awards plaintiff $285,000

Merck & Co. has had a good run so far as it fights off plaintiffs saying the company’s osteoporosis drug Fosamax caused them health problems—claiming victory in five of the seven bellwether cases to go to trial. But yesterday, a jury in Manhattan dealt Merck a bit of a blow when it awarded a former Fosamax user $285,000 for her injuries.

Rhoda E. Scheinberg took Fosamax for almost six years and claimed she suffered severe jaw problems due to the drug. The jury, saying Merck failed to properly warn users about the potential harmful effects of Fosamax, found in Scheinberg’s favor.


Cathleen Flahardy

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.